Senator Ron Johnson @SenRonJohnson
.@NIH: This trial supports using CDCM on day 1 (4 hours after the initial dose) to reduce the SARS-CoV-2 viral load in saliva. For long-term effect (7 days), CDMC appears to provide a modest benefit compared with placebo in reducing viral load in saliva. https://t.co/VeXd3zmlEG — PolitiTweet.org
Heartland Signal @HeartlandSignal
JUST NOW: Ron Johnson, on a Wisconsin tele-town hall, pushes mouthwash as a COVID treatment. "By the way, standard… https://t.co/6tP9UkYMxI